MorphoSys AG
MorphoSys AG (MPSYF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MPSYF · as of Jun 8, 2026
Key Statistics
Explore MorphoSys AG Data
mpsyf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
mpsyf competitorsMPSYF
ARHCF
ASPHF
BIESF
INVVY
IZQVFStock Performance
Full HistoryAbout MorphoSys AG
MorphoSys AG a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune dis…
what is morphosys ag · mpsyf stock overview · morphosys ag company profile · who is morphosys ag ceo · mpsyf OTC · morphosys ag headquarters · morphosys ag business segments
About Stock Overview & Key Data
MorphoSys AG (MPSYF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 28, 2010. As of the latest trading session, MPSYF stock price is $73.27, with a market capitalization of $2.8B. The stock has returned +107.98% over the past 12 months and +90.56% year-to-date.
According to 7 Wall Street analysts, the consensus rating for MorphoSys AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, MorphoSys AG reported revenue of $238.3M and net income of -$189.7M. For detailed data — including MorphoSys AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MorphoSys AG (MPSYF) stock price is $73.27. The stock is traded on OTC under the ticker symbol MPSYF. The 52-week range is $25.56 – $73.27.